Rhythm Pharmaceuticals (RYTM) Stock Chart & Stock Price History $88.30 +3.07 (+3.60%) Closing price 04:00 PM EasternExtended Trading$88.32 +0.02 (+0.02%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Rhythm Pharmaceuticals Stock Price Performance The Rhythm Pharmaceuticals (RYTM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 88.51%, with a year-to-date return of 57.73%. In the past month, the stock has increased 34.93%, reflecting recent market activity. As of the latest close, Rhythm Pharmaceuticals traded at $85.23 with a market cap of $5.42 billion and volume of 472,989 shares. Five years ago, the stock traded at $19.22, representing a 359.42% increase over that period. At the time, it had a market cap of $847.41 million and a volume of 164,372 shares. Receive RYTM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.14%1 Month Performance+34.93%3 Month Performance+38.40%Year-To-Date Performance+57.73%1 Year Performance+88.51%5 Year Performance+359.42% RYTM Stock Chart for Friday, August, 1, 2025 RYTM Chart by TradingView Rhythm Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/31/2025$84.66$85.23+0.67%$86.67$83.98472,989 shs$5.42 billion07/30/2025$85.63$84.66-1.13%$87.09$84.14517,776 shs$5.39 billion07/29/2025$85.68$85.63-0.06%$85.93$84.72418,777 shs$5.45 billion07/28/2025$86.45$85.68-0.89%$86.88$84.22653,752 shs$5.45 billion07/25/2025$87.27$86.45-0.94%$87.34$85.81402,780 shs$5.50 billion07/24/2025$87.81$87.27-0.61%$88.36$86.75388,632 shs$5.55 billion07/23/2025$87.82$87.81-0.01%$89.25$86.86532,583 shs$5.59 billion07/22/2025$88.63$87.82-0.91%$89.67$87.10551,578 shs$5.59 billion07/21/2025$89.20$88.63-0.64%$90.11$87.86667,966 shs$5.64 billion07/18/2025$90.68$89.20-1.63%$91.39$88.60624,068 shs$5.67 billion Get the Latest News and Ratings for RYTM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/17/2025$91.44$90.68-0.83%$92.08$90.31664,259 shs$5.77 billion07/16/2025$89.36$91.44+2.33%$92.14$88.92727,203 shs$5.82 billion07/15/2025$89.15$89.36+0.24%$90.14$87.68852,325 shs$5.69 billion07/14/2025$86.70$89.15+2.83%$89.49$86.67736,625 shs$5.67 billion07/11/2025$89.04$86.70-2.63%$90.36$86.251.11 million shs$5.52 billion07/10/2025$89.00$89.04+0.04%$94.80$87.392.54 million shs$5.66 billion07/09/2025$65.14$89.00+36.63%$89.05$75.014.79 million shs$4.14 billion07/08/2025$66.39$65.14-1.88%$67.17$64.65552,607 shs$4.14 billion07/07/2025$65.78$66.39+0.94%$66.83$65.69821,801 shs$4.22 billion07/04/2025$65.78$65.78$67.44$65.61628,374 shs$4.18 billion07/03/2025$66.92$65.78-1.71%$67.44$65.61628,374 shs$4.18 billion07/02/2025$65.44$66.92+2.26%$67.75$64.81963,104 shs$4.26 billion07/01/2025$63.19$65.44+3.56%$66.21$62.84958,500 shs$4.16 billion06/30/2025$62.73$63.19+0.73%$64.00$62.29785,290 shs$4.02 billion Related Companies Summit Therapeutics Stock Chart Insmed Stock Chart Teva Pharmaceutical Industries Stock Chart Genmab A/S Stock Chart Moderna Stock Chart Dr. Reddy's Laboratories Stock Chart QIAGEN Stock Chart Viatris Stock Chart Ascendis Pharma A/S Stock Chart Verona Pharma PLC American Depositary Share Stock Chart Receive RYTM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RYTM) was last updated on 8/1/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | SponsoredThis New Rule Could Change EverythingA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIf you saw this, you'd be scared tooMarkets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ y...InvestorPlace | SponsoredWhy “The Prophet” Is Betting Big on This $10 StockAmerica's Biggest Land Grab Is Not Where You Think While the media focuses on coastal cities and farmland.....Stansberry Research | SponsoredTop Picks for Trump’s Pro-Crypto America27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rhythm Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rhythm Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RYTM Stock Alerts